抗体-药物联体在瘤学中成熟
Charles Dumontet1, Janice M Reichert2, Peter D Senter3
1CRCL INSERM 1052/CNRS 5286, University of Lyon, Hospices Civils de Lyon, Lyon, France. charles.dumontet@chu-lyon.fr.
Nature reviews. Drug discovery
|June 12, 2023
概括
抗体与药物合物 (ADC) 通过将抗体与强效药物联系起来,提供向癌症治疗. 在ADC技术的进步正在扩大治疗选择,但管理毒性仍然是优化疗效的关键.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体 - 药物结合体 (ADCs) 将单克隆抗体与细胞毒剂合并为向癌症治疗.
- ADCs旨在通过将强大的有效载荷直接传递给瘤细胞来最大限度地减少副作用.
- 在组合疗法和一线治疗中,ADCs的使用越来越多,这凸显了它们日益增长的重要性.
研究的目的:
- 为癌症治疗的ADC开发的最新进展提供全面的概述.
- 讨论ADCs领域的挑战和未来方向.
- 突出瘤指示的扩大范围和ADCs的治疗潜力.
主要方法:
- 关于ADCs的最新科学文献和临床试验数据的审查.
- 分析新兴的ADC技术,包括新型有效载荷和交付系统.
- 讨论管理ADC相关毒性的策略.
主要成果:
- 在ADC技术的显著进步导致了批准和晚期临床试验的增加.
- 目标和有效载荷的多样化正在扩大ADC在各种癌症中的适用性.
- 新型格式和弹头显示出改善内分布和激活的前景.
结论:
- 抗癌药物是一种快速发展的治疗方式,在瘤学中具有不断扩大的临床应用.
- 对ADC设计和毒性管理的持续研究对于最大限度地提高它们的抗癌活性至关重要.
- ADCs在治疗难以治疗的瘤和改善患者治疗结果方面具有显著的前景.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
9.0K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:31Hybridoma Technology
15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K
01:27Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K